Keeping up with the Brexit

This is a big “family” affair as well. As we are all aware Brexit is on our doorstep. We are all waiting for the latest news on the way we exit from the EU. There are different scenarios already on how to act and take steps as a wholesaler. But what will be the end...

Keeping up with the Brexit

This is a big “family” affair as well. As we are all aware Brexit is on our doorstep. We are all waiting for the latest news on the way we exit from the EU. There are different scenarios already on how to act and take steps as a wholesaler. But what will be the end...

Parallel Imports – Lorna Welbourn

The UK Parallel Importing scheme allows for a medicinal product authorised in another EU member state to be marketed in the UK providing there is no therapeutic difference.  In order to parallel import (PI) and repackage medicinal products, relevant licences would be...

MHRA GDP SYMPOSIUM 2018

The MHRA GDP Symposium heralds the end of the year and the opportunity to mull over any advice on Regulatory changes and Inspectorate trends. The chance for clarity and what will be expected for (very) near future changes to trading laws and status – ...

SOP review is in our agenda for 2019

Brexit will definitely make wholesalers review their standard operating procedures (SOPs) to comply with the new laws and regulations. Will have to looking at reviewing of key procedures, documentations and policies to reflect the upcoming changes. What kind of...

What a no deal Brexit could mean for UK GDP & GMP.

MHRA have confirmed that in the event of a no deal Brexit they will be a stand-alone regulator making decisions and functions with a pragmatic approach to current EU standards.  They currently have 51 high priority tasks that still need to be implemented for day...